Advances in the targeted therapy for chronic lymphocytic leukemia in the 54th ASH annual meeting / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 193-196,201, 2013.
Artículo
en Chino
| WPRIM
| ID: wpr-602003
ABSTRACT
Recognition has been achieved in the molecular targeting of several key signaling transduction pathways governing cell survival and proliferation in chronic lymphocytic leukemia (CLL).A milestone in CLL treatment is reached.This review provides a brief summary of the 54th ASH annual meeting,focusing on recent advances in the preclinical and clinical investigation of promising target-directed therapeutic agents.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS